We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

The Chinese pharmaceutical market is already more advanced than many in the West imagine – and it only looks set to go in one direction.

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?

Struggling with process research and development? Find yourself a CRO that knows what it’s doing.

The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.

Successes in the cell and gene therapy field show us that great advances can be made – without taking unnecessary risks.

When it comes to the crunch – the swab test – planning and preparation are the key to the best performance.

With all the hope and promise emanating from the cell and gene therapy field today, it’s easy to forget that we’ve had false dawns in the past.

If you or your supplier are working with animal-derived components, you run the risk of exposing patients to dangerous contaminations.